A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Miriam Bosch,Nina Kallin,Sainitin Donakonda,Jitao David Zhang,Hannah Wintersteller,Silke Hegenbarth,Kathrin Heim,Carlos Ramirez,Anna Fürst,Elias Isaac Lattouf,Martin Feuerherd,Sutirtha Chattopadhyay,Nadine Kumpesa,Vera Griesser,Jean-Christophe Hoflack,Juliane Siebourg-Polster,Carolin Mogler,Leo Swadling,Laura J Pallett,Philippa Meiser,Katrin Manske,Gustavo P de Almeida,Anna D Kosinska,Ioana Sandu,Annika Schneider,Vincent Steinbacher,Yan Teng,Julia Schnabel,Fabian Theis,Adam J Gehring,Andre Boonstra,Harry L A Janssen,Michiel Vandenbosch,Eva Cuypers,Rupert Öllinger,Thomas Engleitner,Roland Rad,Katja Steiger,Annette Oxenius,Wan-Lin Lo,Victoria Klepsch,Gottfried Baier,Bernhard Holzmann,Mala K Maini,Ron Heeren,Peter J Murray,Robert Thimme,Carl Herrmann,Ulrike Protzer,Jan P Böttcher,Dietmar Zehn,Dirk Wohlleber,Georg M Lauer,Maike Hofmann,Souphalone Luangsay,Percy A Knolle
DOI: https://doi.org/10.1038/s41586-024-07630-7
IF: 64.8
Nature
Abstract:Chronic hepatitis B virus (HBV) infection affects 300 million patients worldwide1,2, in whom virus-specific CD8 T cells by still ill-defined mechanisms lose their function and cannot eliminate HBV-infected hepatocytes3-7. Here we demonstrate that a liver immune rheostat renders virus-specific CD8 T cells refractory to activation and leads to their loss of effector functions. In preclinical models of persistent infection with hepatotropic viruses such as HBV, dysfunctional virus-specific CXCR6+ CD8 T cells accumulated in the liver and, as a characteristic hallmark, showed enhanced transcriptional activity of cAMP-responsive element modulator (CREM) distinct from T cell exhaustion. In patients with chronic hepatitis B, circulating and intrahepatic HBV-specific CXCR6+ CD8 T cells with enhanced CREM expression and transcriptional activity were detected at a frequency of 12-22% of HBV-specific CD8 T cells. Knocking out the inhibitory CREM/ICER isoform in T cells, however, failed to rescue T cell immunity. This indicates that CREM activity was a consequence, rather than the cause, of loss in T cell function, further supported by the observation of enhanced phosphorylation of protein kinase A (PKA) which is upstream of CREM. Indeed, we found that enhanced cAMP-PKA-signalling from increased T cell adenylyl cyclase activity augmented CREM activity and curbed T cell activation and effector function in persistent hepatic infection. Mechanistically, CD8 T cells recognizing their antigen on hepatocytes established close and extensive contact with liver sinusoidal endothelial cells, thereby enhancing adenylyl cyclase-cAMP-PKA signalling in T cells. In these hepatic CD8 T cells, which recognize their antigen on hepatocytes, phosphorylation of key signalling kinases of the T cell receptor signalling pathway was impaired, which rendered them refractory to activation. Thus, close contact with liver sinusoidal endothelial cells curbs the activation and effector function of HBV-specific CD8 T cells that target hepatocytes expressing viral antigens by means of the adenylyl cyclase-cAMP-PKA axis in an immune rheostat-like fashion.